Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
2 studies found for:    18523152 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Ipilimumab and Sargramostim in Treating Patients With Metastatic Prostate Cancer
Conditions: Recurrent Prostate Carcinoma;   Stage IV Prostate Cancer
Interventions: Biological: Ipilimumab;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Biological: Sargramostim
2 Unknown  Granulocyte Macrophage-Colony Stimulating Factor and Ipilimumab as Therapy in Melanoma
Condition: Malignant Melanoma, Metastatic
Interventions: Biological: Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF);   Biological: Ipilimumab

Study has passed its completion date and status has not been verified in more than two years.